established companies. For these and other reasons, the investments
discussed or recommended in this report may be unsuitable for investors
depending on their specific investment objectives and financial position.
Transactions in securities mentioned herein may be effected only in those
states where such securities are qualified for sale.
Any statements nonfactual in nature herein constitute only current
opinions or estimates, represent only the current judgment of the
author(s), and are subject to change without notice. This report contains
forward-looking statements, which involve risks and uncertainties. Actual
results may differ significantly from the results described in the
forward-looking statements. Emerging Growth Equities, Ltd. (or one of its
affiliates) or their partners, officers, directors, analysts, employees or
customers may have an interest in the securities mentioned herein and may
make purchases or sales as principal or agent of these securities, or their
derivatives, while this report is in circulation. A partner, employee,
analyst, officer, or director of Emerging Growth Equities, Ltd. (or one of
its affiliates) may serve as a director or consultant for any company
mentioned herein. Emerging Growth Equities, Ltd. (or one of its affiliates)
may from time to time perform investment banking services for, or solicit
investment banking business or other business from, any company mentioned
herein. Additional information on the securities discussed herein is
available on request.
Emerging Growth Equities, Ltd. is a member of the Financial Industry
Regulatory Authority, CRD number 47040.
'/>"/>SOURCE Emerging Growth Equities, Ltd. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
Oral Drug From Novartis/Mitsubishi Tanabe Will Capture the Largest Market Share of All Emerging Multiple Sclerosis Therapies in 20172.
BioNanomatrix Named Best Management Team at the 2008 Ben Franklin Emerging Business Awards3.
Pharsight to Present at Jesup and Lamont 2008 Emerging Growth Stock Conference4.
CyberKnife Users Meeting Highlights Major Clinical Data Milestones and Emerging Trends5.
Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference6.
Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum7.
NanoMaterials Technology to Conduct Process Development Feasibility Study with US Based Emerging Pharmaceutical Company8.
Project on Emerging Nanotechnologies and Consumers Union collaborate on ConsumersTalkNano9.
Luminex Corporation to Present at Americas Growth Capital Emerging Growth Conference10.
Neurocrine Biosciences to Present at the A.G. Edwards Annual Emerging Growth Conference11.
Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference